Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Longitudinal registry data evaluating oral ingestion timing, restorative sleep scores, and morning cognitive clarity across varied cannabinoid formulation profiles. Derived from longitudinal physician evaluations across 81,008 unique clinical cohorts and 130,447 structured follow-up encounters at CED Clinic, informed by Dr. Benjamin Caplan’s career oversight of 350,000+ patient evaluations.
Methodology & Observational Grounding
Unlike traditional pharmaceutical clinical trials that restrict inclusion criteria to single-diagnosis participants devoid of concurrent medications, the CED Clinic Real-World Evidence Registry captures the complex clinical reality of outpatient cannabinoid medicine. Patients in this cohort were systematically evaluated under board-certified physician supervision, with structured longitudinal tracking of symptom burden, medication de-escalation, adverse event incidence, and chemovar responsiveness.
What does real-world evidence show regarding cannabinoids for Sleep Architecture & Insomnia?
Patients utilizing balanced multi-cannabinoid formulations incorporating cannabinol (CBN) and cannabidiol (CBD) report superior morning cognitive restoration compared to high-potency THC monotherapy, which frequently causes sleep architecture fragmentation and daytime hangover.
What is the clinical scale and data provenance of this Sleep Architecture & Insomnia analysis?
This analysis synthesizes real-world clinical observations from Dr. Benjamin Caplan, MD, who has overseen more than 350,000 patient evaluations across his career (including supervising 250,000+ patients as former Chief Medical Officer of Canna Care Docs). The specific dataset reflects 81,008 outpatient cohorts and 130,447 structured clinical visits tracked in the CED Clinic Clinical Registry.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
“Patients utilizing balanced multi-cannabinoid formulations incorporating cannabinol (CBN) and cannabidiol (CBD) report superior morning cognitive restoration compared to high-potency THC monotherapy, which frequently causes sleep architecture fragmentation and daytime hangover.”